nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA4—autonomic nervous system—Gilles de la Tourette syndrome	0.0479	0.0907	CbGeAlD
Galantamine—CHRNA5—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0317	0.0671	CbGpPWpGaD
Galantamine—CHRNA5—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0308	0.0652	CbGpPWpGaD
Galantamine—ACHE—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.0291	0.0616	CbGpPWpGaD
Galantamine—CHRNA5—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0287	0.0607	CbGpPWpGaD
Galantamine—CHRNB3—midbrain—Gilles de la Tourette syndrome	0.0246	0.0466	CbGeAlD
Galantamine—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.024	0.0509	CbGpPWpGaD
Galantamine—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0233	0.0494	CbGpPWpGaD
Galantamine—CHRNA5—nervous system—Gilles de la Tourette syndrome	0.0223	0.0422	CbGeAlD
Galantamine—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0217	0.046	CbGpPWpGaD
Galantamine—CHRNA5—central nervous system—Gilles de la Tourette syndrome	0.0214	0.0406	CbGeAlD
Galantamine—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0211	0.0448	CbGpPWpGaD
Galantamine—CHRNA6—midbrain—Gilles de la Tourette syndrome	0.0205	0.0389	CbGeAlD
Galantamine—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0205	0.0435	CbGpPWpGaD
Galantamine—CHRNB3—nervous system—Gilles de la Tourette syndrome	0.0202	0.0383	CbGeAlD
Galantamine—CHRNB3—central nervous system—Gilles de la Tourette syndrome	0.0195	0.0369	CbGeAlD
Galantamine—CHRNG—midbrain—Gilles de la Tourette syndrome	0.0194	0.0367	CbGeAlD
Galantamine—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0191	0.0405	CbGpPWpGaD
Galantamine—CHRNA5—brain—Gilles de la Tourette syndrome	0.017	0.0323	CbGeAlD
Galantamine—CHRNA6—nervous system—Gilles de la Tourette syndrome	0.0169	0.032	CbGeAlD
Galantamine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0167	0.0354	CbGpPWpGaD
Galantamine—CHRNA6—central nervous system—Gilles de la Tourette syndrome	0.0163	0.0308	CbGeAlD
Galantamine—CHRNB3—brain—Gilles de la Tourette syndrome	0.0155	0.0293	CbGeAlD
Galantamine—CHRNB4—nervous system—Gilles de la Tourette syndrome	0.0153	0.029	CbGeAlD
Galantamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0152	0.0323	CbGpPWpGaD
Galantamine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0149	0.0316	CbGpPWpGaD
Galantamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0148	0.0313	CbGpPWpGaD
Galantamine—CHRNB4—central nervous system—Gilles de la Tourette syndrome	0.0148	0.028	CbGeAlD
Galantamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0138	0.0292	CbGpPWpGaD
Galantamine—CHRNA6—brain—Gilles de la Tourette syndrome	0.0129	0.0244	CbGeAlD
Galantamine—CHRNB2—midbrain—Gilles de la Tourette syndrome	0.0118	0.0223	CbGeAlD
Galantamine—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0118	0.0249	CbGpPWpGaD
Galantamine—CHRNB4—brain—Gilles de la Tourette syndrome	0.0117	0.0222	CbGeAlD
Galantamine—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0114	0.0242	CbGpPWpGaD
Galantamine—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0106	0.0226	CbGpPWpGaD
Galantamine—CHRNB1—midbrain—Gilles de la Tourette syndrome	0.0099	0.0187	CbGeAlD
Galantamine—CHRNB2—nervous system—Gilles de la Tourette syndrome	0.0097	0.0184	CbGeAlD
Galantamine—CHRNA3—nervous system—Gilles de la Tourette syndrome	0.00941	0.0178	CbGeAlD
Galantamine—CHRNB2—central nervous system—Gilles de la Tourette syndrome	0.00934	0.0177	CbGeAlD
Galantamine—CHRNA3—central nervous system—Gilles de la Tourette syndrome	0.00905	0.0171	CbGeAlD
Galantamine—CHRNA2—nervous system—Gilles de la Tourette syndrome	0.00874	0.0166	CbGeAlD
Galantamine—ACHE—midbrain—Gilles de la Tourette syndrome	0.00858	0.0163	CbGeAlD
Galantamine—CHRNA2—central nervous system—Gilles de la Tourette syndrome	0.00842	0.0159	CbGeAlD
Galantamine—CHRNA1—brain—Gilles de la Tourette syndrome	0.00805	0.0153	CbGeAlD
Galantamine—CHRFAM7A—nervous system—Gilles de la Tourette syndrome	0.00761	0.0144	CbGeAlD
Galantamine—CHRNB2—brain—Gilles de la Tourette syndrome	0.00741	0.014	CbGeAlD
Galantamine—CHRNA4—midbrain—Gilles de la Tourette syndrome	0.00737	0.014	CbGeAlD
Galantamine—CHRFAM7A—central nervous system—Gilles de la Tourette syndrome	0.00732	0.0139	CbGeAlD
Galantamine—CHRNA3—brain—Gilles de la Tourette syndrome	0.00719	0.0136	CbGeAlD
Galantamine—CHRNA2—brain—Gilles de la Tourette syndrome	0.00668	0.0127	CbGeAlD
Galantamine—CHRNB1—brain—Gilles de la Tourette syndrome	0.00622	0.0118	CbGeAlD
Galantamine—CHRNA7—nervous system—Gilles de la Tourette syndrome	0.00614	0.0116	CbGeAlD
Galantamine—CHRNA4—nervous system—Gilles de la Tourette syndrome	0.00606	0.0115	CbGeAlD
Galantamine—CHRNA7—central nervous system—Gilles de la Tourette syndrome	0.00591	0.0112	CbGeAlD
Galantamine—CHRNA4—central nervous system—Gilles de la Tourette syndrome	0.00583	0.0111	CbGeAlD
Galantamine—CHRFAM7A—brain—Gilles de la Tourette syndrome	0.00581	0.011	CbGeAlD
Galantamine—CHRNA9—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0058	0.0123	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00552	0.0117	CbGpPWpGaD
Galantamine—ACHE—brain—Gilles de la Tourette syndrome	0.00539	0.0102	CbGeAlD
Galantamine—CHRNB3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00507	0.0107	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00481	0.0102	CbGpPWpGaD
Galantamine—CHRNA7—brain—Gilles de la Tourette syndrome	0.0047	0.00889	CbGeAlD
Galantamine—CHRNA4—brain—Gilles de la Tourette syndrome	0.00463	0.00877	CbGeAlD
Galantamine—CHRNG—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00458	0.00971	CbGpPWpGaD
Galantamine—CHRNA9—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00444	0.00941	CbGpPWpGaD
Galantamine—CHRNE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00431	0.00913	CbGpPWpGaD
Galantamine—BCHE—midbrain—Gilles de la Tourette syndrome	0.00422	0.00799	CbGeAlD
Galantamine—CHRNB3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00388	0.00823	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00368	0.0078	CbGpPWpGaD
Galantamine—CHRNA6—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00364	0.00772	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00351	0.00744	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00347	0.00735	CbGpPWpGaD
Galantamine—BCHE—nervous system—Gilles de la Tourette syndrome	0.00347	0.00657	CbGeAlD
Galantamine—CHRNB2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00337	0.00714	CbGpPWpGaD
Galantamine—BCHE—central nervous system—Gilles de la Tourette syndrome	0.00334	0.00632	CbGeAlD
Galantamine—CHRNE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0033	0.007	CbGpPWpGaD
Galantamine—CHRNB2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00321	0.00679	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00314	0.00665	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00279	0.00591	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00269	0.0057	CbGpPWpGaD
Galantamine—BCHE—brain—Gilles de la Tourette syndrome	0.00265	0.00502	CbGeAlD
Galantamine—CHRND—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00255	0.0054	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00252	0.00535	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00246	0.0052	CbGpPWpGaD
Galantamine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00233	0.00442	CbGeAlD
Galantamine—CHRNA3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00231	0.00489	CbGpPWpGaD
Galantamine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.0023	0.00435	CbGeAlD
Galantamine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00225	0.00426	CbGeAlD
Galantamine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00221	0.00419	CbGeAlD
Galantamine—CHRNA7—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00219	0.00464	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00217	0.00459	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00212	0.00449	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00206	0.00436	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00195	0.00414	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00193	0.0041	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00184	0.0039	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00179	0.00378	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00177	0.00375	CbGpPWpGaD
Galantamine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00176	0.00333	CbGeAlD
Galantamine—CHRNA7—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00168	0.00356	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00166	0.00352	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00158	0.00334	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.0015	0.00318	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00137	0.0029	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00127	0.0027	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00114	0.00241	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000976	0.00207	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000871	0.00185	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.000706	0.0015	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.00063	0.00134	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00029	0.000614	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000189	0.000401	CbGpPWpGaD
